Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 32

    1.

    Fibrinolytic agents for the management of ST-segment elevation myocardial infarction.

    Hilleman DE, Tsikouris JP, Seals AA, Marmur JD.

    Pharmacotherapy. 2007 Nov;27(11):1558-70. Review.PMID: 17963464 [PubMed - indexed for MEDLINE]Related articles

    2.

    Pharmacogenomics of renin angiotensin system inhibitors in coronary artery disease.

    Tsikouris JP, Peeters MJ.

    Cardiovasc Drugs Ther. 2007 Apr;21(2):121-32. Review.PMID: 17486303 [PubMed - indexed for MEDLINE]Related articles

    3.

    Evaluation of angiotensin converting enzyme (ACE)-like activity of acellular hemoglobin.

    Simoni J, Simoni G, Moeller JF, Tsikouris JP, Wesson DE.

    Artif Cells Blood Substit Immobil Biotechnol. 2007;35(2):191-210.PMID: 17453704 [PubMed - indexed for MEDLINE]Related articles

    4.

    Role of free hemoglobin in 8-iso prostaglandin F2-alpha synthesis in chronic renal failure and its impact on CD163-Hb scavenger receptor and on coronary artery endothelium.

    Simoni J, Simoni G, Griswold JA, Moeller JF, Tsikouris JP, Khanna A, Roongsritong C, Wesson DE.

    ASAIO J. 2006 Nov-Dec;52(6):652-61.PMID: 17117055 [PubMed - indexed for MEDLINE]Related articles

    5.

    A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients.

    Busti AJ, Tsikouris JP, Peeters MJ, Das SR, Canham RM, Abdullah SM, Margolis DM.

    HIV Med. 2006 Jul;7(5):317-22.PMID: 16945077 [PubMed - indexed for MEDLINE]Related articles

    6.

    Lack of effect on coronary atherosclerotic disease biomarkers with modest dosing of an angiotensin-converting enzyme inhibitor, angiotensin II type-1 receptor blocker, and the combination.

    Tsikouris JP, Cox CD, Simoni JS, Seifert CF, Peek MC, Meyerrose GE.

    Coron Artery Dis. 2006 Aug;17(5):439-45.PMID: 16845252 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of three fluoroquinolones on QT analysis after standard treatment courses.

    Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF.

    Ann Noninvasive Electrocardiol. 2006 Jan;11(1):52-6.PMID: 16472283 [PubMed - indexed for MEDLINE]Related articles

    8.

    Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.

    Peeters MJ, Tsikouris JP.

    Ann Intern Med. 2005 Mar 1;142(5):388; author reply 388-9. No abstract available. PMID: 15738462 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The use of angiotensin receptor blockers in the treatment of chronic heart failure.

    Irons BK, Tsikouris JP, Thomas AA.

    J Cardiovasc Pharmacol. 2004 Dec;44(6):718-24. Review.PMID: 15550793 [PubMed - indexed for MEDLINE]Related articles

    10.

    Potential in vitro interaction between tenecteplase and unfractionated heparin.

    Tsikouris JP, Martin CP, Cox CD, Ziska M, Suarez JA, Meyerrose GE.

    Pharmacotherapy. 2004 Sep;24(9):1154-8.PMID: 15460176 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of effects of quinapril versus enalapril on vasoactive substances following acute myocardial infarction.

    Tsikouris JP, Simoni J, Suarez JA, Sutthiwan P, Ziska M, Meyerrose GE.

    Am J Cardiol. 2004 Sep 1;94(5):641-3, A9.PMID: 15342298 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation.

    Coleman CI, Kalus JS, White CM, Spencer AP, Tsikouris JP, Chung JO, Kenyon KW, Ziska M, Kluger J, Reddy P.

    Pharmacoeconomics. 2004;22(13):877-83.PMID: 15329032 [PubMed - indexed for MEDLINE]Related articles

    13.

    Exploring the effects of ACE inhibitor tissue penetration on vascular inflammation following acute myocardial infarction.

    Tsikouris JP, Suarez JA, Simoni JS, Ziska M, Meyerrose GE.

    Coron Artery Dis. 2004 Jun;15(4):211-7.PMID: 15187573 [PubMed - indexed for MEDLINE]Related articles

    14.

    Preventing contrast nephropathy: what is the best strategy? A review of the literature.

    Cox CD, Tsikouris JP.

    J Clin Pharmacol. 2004 Apr;44(4):327-37. Review.PMID: 15051739 [PubMed - indexed for MEDLINE]Related articles

    15.

    Questioning a class effect: does ACE inhibitor tissue penetration influence the degree of fibrinolytic balance alteration following an acute myocardial infarction?

    Tsikouris JP, Suarez JA, Meyerrose GE, Ziska M, Fike D, Smith J.

    J Clin Pharmacol. 2004 Feb;44(2):150-7.PMID: 14747423 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.

    Kalus JS, Spencer AP, Tsikouris JP, Chung JO, Kenyon KW, Ziska M, Kluger J, White CM.

    Am J Health Syst Pharm. 2003 Nov 15;60(22):2308-12.PMID: 14652979 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions.

    Tsikouris JP, Cox CD.

    Pharmacotherapy. 2003 Sep;23(9):1141-52. Review.PMID: 14524646 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide.

    Caron MF, Kluger J, Tsikouris JP, Ritvo A, Kalus JS, White CM.

    Pharmacotherapy. 2003 Mar;23(3):296-300.PMID: 12627926 [PubMed - indexed for MEDLINE]Related articles

    19.

    Thrombolytic fibrin specificity influences activated partial thromboplastin time prolongation in vitro.

    Tsikouris JP, Ii KC, Fike DS, Cox CD, Meyerrose GE, Seifert CF.

    Blood Coagul Fibrinolysis. 2002 Dec;13(8):725-31.PMID: 12441912 [PubMed - indexed for MEDLINE]Related articles

    20.

    Plasminogen activator inhibitor-1: physiologic role, regulation, and the influence of common pharmacologic agents.

    Tsikouris JP, Suarez JA, Meyerrose GE.

    J Clin Pharmacol. 2002 Nov;42(11):1187-99. Review.PMID: 12412817 [PubMed - indexed for MEDLINE]Related articles

    21.

    A comparison of two individual amiodarone regimens to placebo in open heart surgery patients.

    White CM, Giri S, Tsikouris JP, Dunn A, Felton K, Reddy P, Kluger J.

    Ann Thorac Surg. 2002 Jul;74(1):69-74.PMID: 12118806 [PubMed - indexed for MEDLINE]Related articles

    22.

    An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery.

    Reddy P, Dunn AB, White CM, Tsikouris JP, Giri S, Kluger J.

    Pharmacotherapy. 2002 Jan;22(1):75-80.PMID: 11794433 [PubMed - indexed for MEDLINE]Related articles

    23.

    A review of class III antiarrhythmic agents for atrial fibrillation: maintenance of normal sinus rhythm.

    Tsikouris JP, Cox CD.

    Pharmacotherapy. 2001 Dec;21(12):1514-29. Review.PMID: 11765303 [PubMed - indexed for MEDLINE]Related articles

    24.

    Changes in P-wave dispersion and P-wave duration after open heart surgery are associated with the peak incidence of atrial fibrillation.

    Tsikouris JP, Kluger J, Song J, White CM.

    Heart Lung. 2001 Nov-Dec;30(6):466-71.PMID: 11723451 [PubMed - indexed for MEDLINE]Related articles

    25.

    An evaluation of the hemostatic effects of hydrophilic, alcohol, and lipophilic extracts of notoginseng.

    White CM, Fan C, Song J, Tsikouris JP, Chow M.

    Pharmacotherapy. 2001 Jul;21(7):773-7.PMID: 11444574 [PubMed - indexed for MEDLINE]Related articles

    26.

    Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial.

    Giri S, White CM, Dunn AB, Felton K, Freeman-Bosco L, Reddy P, Tsikouris JP, Wilcox HA, Kluger J.

    Lancet. 2001 Mar 17;357(9259):830-6.PMID: 11265951 [PubMed - indexed for MEDLINE]Related articles

    27.

    A placebo controlled evaluation of the antifibrillatory effects of carvedilol.

    Xie J, Dunn A, Tsikouris JP, Sun Y, Fan C, Kluger J, Chow MS, White CM.

    J Electrocardiol. 2001 Jan;34(1):25-30.PMID: 11239367 [PubMed - indexed for MEDLINE]Related articles

    28.

    A review of available fibrin-specific thrombolytic agents used in acute myocardial infarction.

    Tsikouris JP, Tsikouris AP.

    Pharmacotherapy. 2001 Feb;21(2):207-17. Review.PMID: 11213858 [PubMed - indexed for MEDLINE]Related articles

    29.

    Usefulness of intravenous granisetron for prevention of neurally mediated hypotension upon head upright tilt testing.

    Tsikouris JP, Kluger J, Chow MS, White CM.

    Am J Cardiol. 2000 May 15;85(10):1262-4. No abstract available. PMID: 10802016 [PubMed - indexed for MEDLINE]Related articles

    30.

    A review of pathophysiology and therapy of patients with vasovagal syncope.

    White CM, Tsikouris JP.

    Pharmacotherapy. 2000 Feb;20(2):158-65. Review.PMID: 10678294 [PubMed - indexed for MEDLINE]Related articles

    31.

    Optimizing oral dosing and monitoring of noncardiac toxicities with chronic amiodarone therapy.

    Tsikouris JP, White CM, Kluger J.

    Conn Med. 2000 Jan;64(1):35-8. Review. No abstract available. PMID: 10697362 [PubMed - indexed for MEDLINE]Related articles

    32.

    Optimizing the use of ACE inhibitors in patients with congestive heart failure.

    Tsikouris JP.

    Conn Med. 1999 Feb;63(2):91-3. No abstract available. PMID: 10188339 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...